Emodin-8-O-β-D-glucoside

Emodin-8-O-β-D-glucoside is an anthraquinone glycoside derived from plants such as Rheum and Polygonum species, formed by the glucosylation of emodin at the 8-hydroxyl position. It exerts biological activity primarily through activation of PPARα/γ and AMPK signaling pathways, 5-HT1B serotonin receptor agonism, and direct antiviral enzyme inhibition.

Origin & History

Emodin-8-O-β-D-glucoside is a hydroxyanthraquinone glycoside derived from plants like Aloe vera and garden rhubarb. It is produced through centrifugal partition chromatography, isolating it as a pale yellow to brown solid powder.

Historical & Cultural Context

While Emodin-8-O-β-D-glucoside itself is not noted for traditional use, it is found in plants like rhubarb and Reynoutria multiflora, which have historical medicinal applications. Direct historical links to this compound are not established. [3,5]

Health Benefits

• Exhibits antiviral effects through in vitro studies, suggesting potential in viral inhibition. [4,8]
• Acts as a 5-HT1B agonist, which may influence serotonin pathways. [4,7]
• Activates PPARα/γ and AMPK pathways, contributing to various biological activities. [4,7]
• Demonstrates enzyme inhibition properties in animal models. [1,8]
• Possesses immunomodulatory effects, as evidenced in preclinical studies. [4]

How It Works

Emodin-8-O-β-D-glucoside activates peroxisome proliferator-activated receptors PPARα and PPARγ alongside AMP-activated protein kinase (AMPK), modulating lipid metabolism and cellular energy homeostasis. It acts as an agonist at the 5-HT1B serotonin receptor, potentially influencing neurotransmitter signaling and vascular tone. Additionally, it demonstrates inhibitory activity against viral enzymes and select metabolic enzymes, with in vitro data suggesting interference with viral replication machinery.

Scientific Research

No human clinical trials or meta-analyses are available for Emodin-8-O-β-D-glucoside, with research limited to in vitro and animal studies. No PubMed PMIDs are reported for its evaluation in human subjects. [6]

Clinical Summary

Current evidence for emodin-8-O-β-D-glucoside is largely limited to in vitro cell-based assays and preclinical animal models, with no published randomized controlled human clinical trials specifically isolating this compound. In vitro studies have demonstrated antiviral activity, PPARα/γ activation, and AMPK pathway engagement, but quantified effect sizes and therapeutic concentrations have not been validated in human subjects. Animal model data suggest potential metabolic and anti-inflammatory outcomes, though translational relevance remains uncertain. Overall, the evidence base is preliminary and insufficient to establish clinical recommendations or effective human dosages.

Nutritional Profile

Emodin-8-O-β-D-glucoside (also known as emodin-8-glucoside) is not a nutritional substance but rather a bioactive anthraquinone glycoside. It is the 8-O-β-D-glucopyranoside derivative of emodin (1,3,8-trihydroxy-6-methylanthraquinone). Molecular formula: C₂₁H₂₀O₁₀; molecular weight: ~432.38 g/mol. It is found naturally in several medicinal plants, notably Rheum palmatum (rhubarb), Polygonum multiflorum (fo-ti), Polygonum cuspidatum (Japanese knotweed), and Cassia species, typically at concentrations ranging from approximately 0.01–0.5% dry weight depending on plant source, tissue, and extraction method. As a glycosylated anthraquinone, it contains no significant macronutrients (protein, fat, carbohydrate, or fiber) in pharmacologically relevant doses. Key bioactive characteristics: the glucose moiety at the C-8 position increases aqueous solubility relative to free emodin, potentially improving gastrointestinal absorption but also making it a substrate for β-glucosidase-mediated hydrolysis in the gut, which can release free emodin (the aglycone) as an active metabolite. Bioavailability notes: oral bioavailability is considered low to moderate; the compound undergoes extensive first-pass metabolism including deglycosylation by intestinal microflora and phase II conjugation (glucuronidation and sulfation) in the liver. Plasma concentrations after oral dosing in animal models are typically in the low micromolar range. No vitamins or minerals are associated with this compound. It is consumed not for nutritional value but for its pharmacological properties, including anthraquinone-mediated laxative activity, antiviral effects, PPARα/γ and AMPK pathway activation, 5-HT1B receptor agonism, and immunomodulatory actions. Typical experimental doses in preclinical studies range from 10–100 mg/kg body weight in rodent models; human-equivalent dosing has not been well established.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Aloe vera, garden rhubarb, PPARα activators, 5-HT1B agonists, AMPK pathway activators

Safety & Interactions

Human safety data specific to emodin-8-O-β-D-glucoside are lacking, though its parent compound emodin has demonstrated potential genotoxicity and laxative effects at higher doses in preclinical studies, warranting caution. Due to PPARγ activation, interactions with insulin sensitizers such as thiazolidinediones (e.g., rosiglitazone) are theoretically possible, risking additive hypoglycemic effects. AMPK activation may theoretically potentiate the effects of metformin or other AMPK-targeting agents. Pregnant or breastfeeding individuals should avoid this compound given the absence of safety data and the known concerns surrounding anthraquinone glycosides as a class.